InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-1.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by MCCLUSKI STEPHEN C. Officer active across 2 companies, notably MONRO, INC.. Cumulatively, 8 disclosures have been published. Activity tracked since 6 August 2021. The latest transaction was disclosed on 13 August 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
4,937 shares0Restricted Stock AwardSEC:0000950170-24-097535:0
10,000 shares@ US$14.70100.0% of flowCommon StockSEC:0001415889-23-013291:0
3,749 shares0Restricted Stock AwardsSEC:0001209191-23-046178:0
2,426 shares0Restricted Stock AwardsSEC:0001209191-22-046562:0
2,351 shares0Restricted Stock AwardSEC:0001209191-21-052487:0
2,351 shares0Restricted Stock AwardSEC:0001209191-21-052487
10,000 shares@ US$57.780.11% mcap50.0% of flowCommon StockSEC:0001209191-21-050609:0
10,000 shares@ US$57.7850.0% of flowCommon StockSEC:0001209191-21-050609
8 of 8 declarations
About MCCLUSKI STEPHEN C
MCCLUSKI STEPHEN C is a declarant linked to MONRO, INC. and ImmunoGen, Inc., where he is Director. The record shows 8 filings in total, and, across the sampled recent filings held, buy and sell amounts are 0 EUR each, with filings dated from 2021-08-10 to 2024-08-15; the modal transaction nature is Attribution.
